A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Nov 18, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q for Q3 FY2026, filed Nov 9, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the RKLB SEC filings page.
Rocket Lab Corporation (RKLB) reported $881.9M in revenue over the twelve months to Sep 30, 2026, up 59.0% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 6 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Rocket Lab’s growth is widening gross margins, but heavier development and capital spending still keep the business deeply cash-consuming.
Revenue grew38.0% while gross margin reached34.4% . Yet operating margin was-38.0% , indicating that additional gross profit is being absorbed by a still-heavy development program, with R&D equal to45.0% of revenue.
The net loss of
Assets expanded
Financial Health Signals
Scored against emerging companies for FY2025. Each of the six dimensions is a percentile rank within that peer group, and the overall is the average of the dimensions that can be computed. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Rocket Lab Corporation's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Rocket Lab Corporation held $1.1B in cash, cash equivalents and investments at the end of fiscal year 2025, and its operations used $165.5M of cash that year. Cash Runway ranks emerging companies on the size of that balance against the outflow behind it, and Rocket Lab Corporation scores 76/100 among other emerging companies.
Dilution ranks emerging companies on the yearly rate at which their shares outstanding grew across the last three fiscal years (the last two where the earliest reports none), a slower rise ranking higher because each round of funding spreads the same business across more owners. Rocket Lab Corporation scores 62/100 on it among other emerging companies.
Rocket Lab Corporation spent $270.7M on research and development in fiscal year 2025, which was 32.6% of its operating costs that year. R&D Intensity ranks emerging companies on the share of operating costs that goes into research, and Rocket Lab Corporation scores 65/100 among other emerging companies.
Revenue Progress ranks emerging companies on the yearly rate at which their revenue compounded across the last three fiscal years (the last two where the earliest reports none), counted in the currency each company reports in. Rocket Lab Corporation scores 80/100 on it among other emerging companies.
Burn Trend ranks emerging companies on how far their operating cash flow moved between the newest fiscal year and the one two years earlier, measured against the cash the earlier year used, and a move toward generating cash ranks higher. Rocket Lab Corporation scores 26/100 on it among other emerging companies.
Rocket Lab Corporation's cash, cash equivalents and investments came to $1.1B at the end of fiscal year 2025, against $602.6M of total liabilities. Balance Sheet ranks emerging companies on that comparison, and Rocket Lab Corporation scores 73/100 among other emerging companies.
Rocket Lab Corporation scores 35.42, well above the 2.99 safe threshold. The largest contribution to the score comes from a market capitalization of $35.7B against total liabilities of $602.6M. This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Rocket Lab Corporation passes 5 of 9 financial strength tests. 2 of 4 profitability signals pass, 2 of 3 leverage/liquidity signals pass, 1 of 2 operating efficiency signals passes.
Rocket Lab Corporation reported a net loss of $198.2M while operations used $165.5M of cash. With neither figure positive, the ratio between the two carries no quality signal.
Rocket Lab Corporation reported an operating loss of $228.8M against $26.5M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.
Key Financial Metrics
Earnings & Revenue
Rocket Lab Corporation generated $267.8M in revenue in Q3 2026. This represents an increase of 72.7% from the same quarter a year earlier. Against the prior quarter it is up 14.4%.
Rocket Lab Corporation's EBITDA was -$57.7M in Q3 2026, measuring earnings before interest, taxes, depreciation, and amortization. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.
Rocket Lab Corporation reported a net loss of $79.7M in Q3 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.
Rocket Lab Corporation earned -$0.12 per diluted share (EPS) in Q3 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.
Cash & Balance Sheet
Rocket Lab Corporation recorded an outflow of $23.9M in free cash flow in Q3 2026, representing a cash shortfall after capex. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.
Rocket Lab Corporation held $4.4B in cash against $1.7M in long-term debt as of Q3 2026.
Not reported for Q3 2026.
Margins & Returns
Rocket Lab Corporation's gross margin was 33.6% in Q3 2026, indicating the percentage of revenue retained after direct costs. This is down 3.3 percentage points from the same quarter a year earlier. Against the prior quarter it is down 2.5 percentage points.
Rocket Lab Corporation's operating margin was -29.6% in Q3 2026, reflecting core business profitability. This is up 8.4 percentage points from the same quarter a year earlier. Against the prior quarter it is down 5.0 percentage points.
Rocket Lab Corporation's net profit margin was -29.8% in Q3 2026, showing the share of revenue converted to profit. This is down 18.0 percentage points from the same quarter a year earlier. Against the prior quarter it is down 8.7 percentage points.
Rocket Lab Corporation's quarterly ROE was -1.4% in Q3 2026: one quarter's net income over shareholder equity, not annualized. This is up 0.1 percentage points from the same quarter a year earlier. It is unchanged from the prior quarter.
Capital Allocation
Rocket Lab Corporation invested $98.4M in research and development in Q3 2026. This represents an increase of 39.2% from the same quarter a year earlier. Against the prior quarter it is up 19.4%.
Rocket Lab Corporation invested $31.1M in capex in Q3 2026, funding long-term assets and infrastructure. This represents a decrease of 32.3% from the same quarter a year earlier. Against the prior quarter it is up 19.3%.
Not reported for Q3 2026.
RKLB Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Revenue | $267.8M+72.7% | $234.1M+62.0% | $200.3M+63.5% | $179.7M+35.7% | $155.1M+48.0% | $144.5M+36.0% | $122.6M+32.1% | $132.4M+120.7% |
| Cost of Revenue | $177.8M+81.8% | $149.5M+52.4% | $123.9M+41.8% | $111.4M+16.6% | $97.8M+27.3% | $98.1M+24.1% | $87.3M+27.3% | $95.6M+114.8% |
| Gross Profit | $90.1M+57.2% | $84.6M+82.3% | $76.5M+117.0% | $68.2M+85.3% | $57.3M+104.7% | $46.4M+70.8% | $35.2M+45.8% | $36.8M+137.7% |
| R&D Expenses | $98.4M+39.2% | $82.4M+24.6% | $80.5M+46.1% | $78.8M+63.3% | $70.7M+48.1% | $66.1M+65.7% | $55.1M+43.1% | $48.3M+28.7% |
| SG&A Expenses | $70.9M+55.5% | $59.7M+49.6% | $51.9M+32.1% | $40.5M+1.0% | $45.6M+41.7% | $39.9M+30.7% | $39.3M+36.8% | $40.1M+54.9% |
| Operating Income | -$79.2Mn/m | -$57.5Mn/m | -$56.0Mn/m | -$51.0Mn/m | -$59.0Mn/m | -$59.6Mn/m | -$59.2Mn/m | -$51.5Mn/m |
| EBITDA | -$57.7Mn/m | -$38.1Mn/m | -$41.0Mn/m | -$36.3Mn/m | -$47.4Mn/m | -$51.3Mn/m | -$50.5Mn/m | -$42.4Mn/m |
| Interest Expense | $323K-95.6% | $581K-92.1% | $1.3M-81.3% | $11.7M-51.2% | $7.3M+1504.6% | $7.4M+796.8% | $6.8M+656.7% | $24.0M+63.5% |
| Income Tax | $3.5Mn/m | $5.3M+81.3% | -$1.8Mn/m | $11.3M+1570.8% | -$41.1M-4452.9% | $2.9Mn/m | -$813K-16360.0% | $675K-33.2% |
| Net Income | -$79.7Mn/m | -$49.3Mn/m | -$45.0Mn/m | -$52.9Mn/m | -$18.3Mn/m | -$66.4Mn/m | -$60.6Mn/m | -$52.3Mn/m |
| EPS (Basic) | -$0.12n/m | -$0.08n/m | -$0.07n/m | -$0.09n/m | -$0.03n/m | -$0.13n/m | -$0.12n/m | -$0.10n/m |
| EPS (Diluted) | -$0.12n/m | -$0.08n/m | -$0.07n/m | -$0.09n/m | -$0.03n/m | -$0.13n/m | -$0.12n/m | -$0.10n/m |
| Diluted Shares (Avg) | 652M+23.4% | 630M+22.2% | 605M+19.7% | N/A | 529M+6.2% | 515M+4.2% | 506M+3.2% | N/A |
RKLB Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $6.6B+195.7% | $4.2B+169.6% | $2.8B+124.7% | $2.3B+96.3% | $2.2B+92.7% | $1.6B+30.7% | $1.3B+6.2% | $1.2B+25.8% |
| Current Assets | $5.3B+299.0% | $2.9B+187.8% | $1.8B+148.4% | $1.4B+97.2% | $1.3B+89.3% | $1.0B+33.8% | $724.9M-0.1% | $692.6M+45.3% |
| Cash & Equivalents | $4.4B+450.5% | $2.1B+277.5% | $1.2B+297.7% | $828.7M+205.7% | $807.9M+176.2% | $564.1M+65.5% | $303.1M-17.2% | $271.0M+66.8% |
| Short-Term Investments | $160.3M-5.1% | $172.7M+39.2% | $177.9M+42.0% | $187.9M+27.0% | $168.9M+12.6% | $124.1M-20.4% | $125.2M-1.1% | $147.9M+79.9% |
| Inventory | $280.9M+93.7% | $266.9M+105.0% | $183.1M+45.8% | $158.4M+33.0% | $145.0M+26.7% | $130.2M+24.6% | $125.6M+25.7% | $119.1M+10.4% |
| Accounts Receivable | $118.3M+100.2% | $112.9M+82.7% | $75.0M+90.2% | $39.0M+7.0% | $59.1M+166.8% | $61.8M+22.4% | $39.4M+26.5% | $36.4M+3.6% |
| Long-Term Investments | $95.9M+107.6% | $85.4M+39.6% | $93.5M+11.4% | $82.2M+35.5% | $46.2M-24.6% | $61.2M+31.8% | $83.9M+22.4% | $60.7M-23.4% |
| Goodwill | $301.4M+38.5% | $299.1M+321.1% | $208.7M+193.9% | $205.8M+189.7% | $217.7M+206.5% | $71.0M0.0% | $71.0M0.0% | $71.0M0.0% |
| Total Liabilities | $766.1M-18.5% | $695.2M-19.6% | $555.6M-32.5% | $602.6M-24.8% | $940.4M+28.3% | $864.7M+17.9% | $823.7M+17.2% | $801.9M+107.4% |
| Current Liabilities | $614.1M+48.2% | $528.2M+40.3% | $402.3M+15.6% | $334.5M-1.5% | $414.5M+54.0% | $376.5M+41.3% | $348.1M+49.8% | $339.5M+52.0% |
| Non-Current Liabilities | $152.0M-71.1% | $167.0M-65.8% | $153.2M-67.8% | $268.1M-42.0% | $526.0M+13.4% | $488.3M+4.6% | $475.6M+1.1% | $462.4M+183.1% |
| Long-Term Debt | $1.7M-96.7% | $1.7M-96.8% | $1.7M-97.0% | $1.7M-96.1% | $51.3M+9.3% | $53.7M+7.3% | $57.7M+9.5% | $44.0M-49.7% |
| Total Equity | $5.8B+353.0% | $3.5B+407.2% | $2.3B+425.0% | $1.7B+350.2% | $1.3B+205.1% | $688.5M+51.3% | $431.3M-9.9% | $382.5M-31.0% |
| Retained Earnings | -$1.2Bn/m | -$1.1Bn/m | -$1.1Bn/m | -$1.0Bn/m | -$959.0Mn/m | -$940.7Mn/m | -$874.3Mn/m | -$813.7Mn/m |
RKLB Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $7.2Mn/m | -$84.1Mn/m | -$50.3Mn/m | -$64.5Mn/m | -$23.5Mn/m | -$23.2Mn/m | -$54.2Mn/m | -$2.4Mn/m |
| Depreciation & Amortization | $21.5M+85.6% | $19.4M+133.0% | $15.0M+72.2% | $14.7M+61.3% | $11.6M+51.8% | $8.3M+9.0% | $8.7M+4.7% | $9.1M+11.9% |
| Stock-Based Compensation | $18.3M+16.5% | $19.6M+9.1% | $28.1M+46.2% | N/A | $15.7M+22.0% | $17.9M+28.5% | $19.2M+46.9% | N/A |
| Capital Expenditures | $31.1M-32.3% | $26.0M-18.7% | $27.1M-5.6% | $49.7M+130.4% | $45.9M+316.7% | $32.0M+108.8% | $28.7M+49.5% | $21.6M+107.0% |
| Free Cash Flow | -$23.9Mn/m | -$110.1Mn/m | -$77.4Mn/m | -$114.2Mn/m | -$69.4Mn/m | -$55.3Mn/m | -$82.9Mn/m | -$23.9Mn/m |
| Investing Cash Flow | -$29.3Mn/m | -$48.9Mn/m | -$35.7Mn/m | -$104.1Mn/m | -$207.2Mn/m | -$7.4Mn/m | -$28.6Mn/m | -$17.9M-129.3% |
| Financing Cash Flow | $2.3B+392.0% | $1.1B+264.9% | $463.3M+301.1% | $189.5M+103472.1% | $475.7Mn/m | $290.5Mn/m | $115.5M-55.4% | $183K-92.7% |
Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.
RKLB Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 33.6%-3.3pp | 36.1%+4.0pp | 38.2%+9.4pp | 38.0%+10.2pp | 37.0%+10.2pp | 32.1%+6.5pp | 28.8%+2.7pp | 27.8%+2.0pp |
| Operating Margin | -29.6%+8.4pp | -24.6%+16.7pp | -27.9%+20.4pp | -28.4%+10.5pp | -38.0%+11.5pp | -41.3%-0.5pp | -48.3%-1.9pp | -38.9%+40.9pp |
| Net Margin | -29.8%-18.0pp | -21.0%+24.9pp | -22.5%+27.0pp | -29.5%+10.1pp | -11.8%+37.8pp | -46.0%-6.8pp | -49.5%-1.7pp | -39.5%+44.6pp |
| Return on Equity | -1.4%+0.1pp | -1.4%+8.2pp | -2.0%+12.1pp | -3.1%+10.6pp | -1.4%+10.9pp | -9.7%-0.5pp | -14.1%-4.8pp | -13.7%-4.6pp |
| Return on Assets | -1.2%-0.4pp | -1.2%+3.1pp | -1.6%+3.2pp | -2.3%+2.1pp | -0.8%+3.7pp | -4.3%-0.8pp | -4.8%-1.1pp | -4.4%+0.9pp |
| Current Ratio | 8.55+5.4x | 5.48+2.8x | 4.47+2.4x | 4.08+2.0x | 3.18+0.6x | 2.67-0.1x | 2.08-1.0x | 2.04-0.1x |
| Debt-to-Equity | 0.000.0x | 0.00-0.1x | 0.00-0.1x | 0.00-0.1x | 0.04-0.1x | 0.080.0x | 0.130.0x | 0.120.0x |
| Liabilities-to-Equity | 0.13-0.6x | 0.20-1.1x | 0.25-1.7x | 0.35-1.7x | 0.73-1.0x | 1.26-0.4x | 1.91+0.4x | 2.10+1.4x |
| Asset Turnover | 0.040.0x | 0.060.0x | 0.070.0x | 0.080.0x | 0.070.0x | 0.090.0x | 0.100.0x | 0.110.0x |
| FCF Margin | -8.9%+35.8pp | -47.0%-8.8pp | -38.6%+29.0pp | -63.6%-45.5pp | -44.8%-4.8pp | -38.3%-11.6pp | -67.6%-44.2pp | -18.1%+69.7pp |
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it. Market cap is stated at each company's latest close.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Rocket Lab Corporation RKLB | FY2025 | $601.8M | -$198.2M | -32.9% | $35.7B | 64/100 |
| L3Harris Technologies, Inc. LHX | FY2026 | N/A | $1.6B | N/A | $47.7B | — |
| Elbit Systems Ltd ESLT | FY2025 | $7.9B | $534.3M | 6.7% | $32.7B | 63/100 |
| HEICO Corporation HEI | FY2025 | $4.5B | $690.4M | 15.4% | $47.3B | 76/100 |
| TransDigm Group Incorporated TDG | FY2026 | $10.6B | $2.1B | 20.0% | $64.3B | 73/100 |
| Northrop Grumman Corp. NOC | FY2025 | $42.0B | $4.2B | 10.0% | $77.1B | 51/100 |
Where Rocket Lab Corporation Ranks
Frequently Asked Questions
Rocket Lab Corporation (RKLB) reported $601.8M in total revenue for fiscal year 2025. This represents a 38.0% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
Rocket Lab Corporation (RKLB) revenue grew by 38.0% year-over-year, from $436.2M to $601.8M in fiscal year 2025.
No, Rocket Lab Corporation (RKLB) reported a net loss of $226.9M over the trailing 12 months to September 30, 2026. In fiscal year 2025 it reported a net loss of $198.2M, with a net profit margin of -32.9%.
Rocket Lab Corporation (RKLB) had EBITDA of -$184.9M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
As of fiscal year 2025, Rocket Lab Corporation (RKLB) had $828.7M in cash and equivalents against $1.7M in long-term debt.
Rocket Lab Corporation (RKLB) had a gross margin of 34.4% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
Rocket Lab Corporation (RKLB) had an operating margin of -38.0% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
Rocket Lab Corporation (RKLB) had a net profit margin of -32.9% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
Rocket Lab Corporation (RKLB) has a return on equity of -11.5% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
Rocket Lab Corporation (RKLB) recorded an outflow of $321.8M in free cash flow during fiscal year 2025. The change from the previous fiscal year is not meaningful, because that year’s figure was zero or negative. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
Rocket Lab Corporation (RKLB) recorded an outflow of $165.5M in operating cash flow during fiscal year 2025, representing cash used by core business activities.
Rocket Lab Corporation (RKLB) had $2.3B in total assets as of fiscal year 2025, including both current and long-term assets.
Rocket Lab Corporation (RKLB) invested $156.3M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
Rocket Lab Corporation (RKLB) invested $270.7M in research and development during fiscal year 2025.
Rocket Lab Corporation (RKLB) had a current ratio of 4.08 as of fiscal year 2025, which is generally considered healthy.
Rocket Lab Corporation (RKLB) had a debt-to-equity ratio of 0.00 as of fiscal year 2025. We compute it as long-term debt divided by total shareholder equity, where long-term debt is the noncurrent part of the company's borrowings, so debt due within the next twelve months is not counted.
Rocket Lab Corporation (RKLB) had a liabilities-to-equity ratio of 0.35 as of fiscal year 2025, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity.
Rocket Lab Corporation (RKLB) had a return on assets of -8.5% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
Rocket Lab Corporation (RKLB) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (trailing 12 months to September 30, 2026). The market capitalization is $35.7B as of Nov 18, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
Rocket Lab Corporation (RKLB) trades at 40.5x sales, its market capitalization divided by $881.9M revenue, trailing 12 months to September 30, 2026. The market capitalization is $35.7B as of Nov 18, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
At the end of fiscal year 2025, Rocket Lab Corporation (RKLB) held $1.1B in cash, cash equivalents and investments, and reported an operating cash outflow of $165.5M over that year. Dividing the one by the other, the reported balance equals about 80 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.
Rocket Lab Corporation (RKLB) has an Altman Z-Score of 35.42, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
Rocket Lab Corporation (RKLB) has a Piotroski F-Score of 5 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Rocket Lab Corporation (RKLB) reported a net loss of $198.2M while operations used $165.5M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Rocket Lab Corporation (RKLB) reported an operating loss of $228.8M against $26.5M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
Rocket Lab Corporation (RKLB) scores 64 out of 100 on our Financial Health Score, indicating moderate standing within its emerging companies peer group. The score is the average of six dimensions (Cash Runway, Dilution, R&D Intensity, Revenue Progress, Burn Trend, Balance Sheet), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.